ReShape Lifesciences® Regains Compliance with Nasdaq Minimum Stockholders Equity Requirement
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 27 2025
0mins
Source: Newsfilter
Company Compliance Update: ReShape Lifesciences Inc. has regained compliance with Nasdaq's stockholders equity requirement, closing the listing matter after previously being notified of potential delisting due to insufficient equity.
Equity Financing Details: The company improved its stockholders' equity from $1.2 million to over $2.5 million by selling shares in two offerings, raising approximately $6.3 million in total.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
